FrancophonIA/ELRC3.0 huggingface dataset:
English: Too high a dose of Puregon may cause hyperstimulation of the ovaries (OHSS).
Icelandic: Of stór skammtur af Puregon getur valdið oförvun eggjastokka.
English: If you use more Puregon than you should
Icelandic: Ef notaður er stærri skammtur en mælt er fyrir um
English: Do not mix any other drug into the cartridges.Empty cartridges must not be refilled.
Icelandic: Ekki má setja annað lyf í rörlykjurnar.
English: In adult females: Puregon is indicated for the treatment of female infertility in the following clinical situations:
Icelandic: Puregon er ætlað til meðferðar við ófrjósemi kvenna við eftirfarandi klínískar aðstæður:
English: CARTRIDGE TEXT Puregon 300 IU/0.36 mL
Icelandic: RÖRLYKJA TEXTI Puregon 300 a.e./0,36 ml
English: The administration of Puregon is then discontinued and ovulation can be induced by administering human chorionic gonadotrophin (hCG).
Icelandic: Þá er Puregon gjöf hætt og hægt er að koma af stað egglosi með því að gefa kóríóngónadótrópín úr mönnum (hCG).
English: VIAL TEXT Puregon 225 IU/0.5 mL
Icelandic: HETTUGLAS TEXTI Puregon 225 a.e./0,5 ml
English: * Women who are not ovulating A starting dose is set by your doctor.
Icelandic: Konur sem hafa ekki egglos Læknirinn ákveður upphafsskammt.
English: It is unlikely that Puregon is passed into breast milk.
Icelandic: Ólíklegt er að Puregon berist í brjóstamjólk.
English: In males Puregon is used in the treatment of deficient spermatogenesis due to hypogonadotrophic hypogonadism.
Icelandic: Hjá körlum er Puregon notað við meðferð á skertri sæðisframleiðslu vegna kynkirtlavanseytingar af völdum gónadótrópínskorts.
English: CARTRIDGE TEXT Puregon 600 IU/0.72 mL
Icelandic: RÖRLYKJA TEXTI Puregon 600 a.e./0,72 ml
English: Puregon 50 IU/0.5 mL solution for injection Puregon 75 IU/0.5 mL solution for injection Puregon 100 IU/0.5 mL solution for injection Puregon 150 IU/0.5 mL solution for injection Puregon 200 IU/0.5 mL solution for injection Puregon 225 IU/0.5 mL solution for injection follitropin beta
Icelandic: Puregon 50 a.e./0,5 ml stungulyf, lausn Puregon 75 a.e./0,5 ml stungulyf, lausn Puregon 100 a.e./0,5 ml stungulyf, lausn Puregon 150 a.e./0,5 ml stungulyf, lausn Puregon 200 a.e./0,5 ml stungulyf, lausn Puregon 225 a.e./0,5 ml stungulyf, lausn follitrópín beta
English: Children There is no relevant use of PUREGON in children.
Icelandic: Börn Puregon er ekki ætlað til notkunar hjá börnum.
English: Puregon solution for injection in cartridges has been developed for use in the Puregon Pen and should be administered subcutaneously.
Icelandic: Puregon stungulyf, lausn í rörlykjum var þróað til notkunar með Puregon Pen og það skal gefið undir húð.
English: There are no significant pharmacokinetic differences between intramuscular and subcutaneous administration of Puregon.
Icelandic: Enginn marktækur munur er á lyfjahvörfum milli Puregon gjafar í vöðva og undir húð.
English: The first injection with Puregon should be performed under direct medical supervision.
Icelandic: Puregon skal gefin undir eftirliti læknis.
English: Puregon 50 IU/0.5 mL solution for injection Puregon 75 IU/0.5 mL solution for injection Puregon 100 IU/0.5 mL solution for injection Puregon 150 IU/0.5 mL solution for injection Puregon 200 IU/0.5 mL solution for injection Puregon 225 IU/0.5 mL solution for injection
Icelandic: Puregon 50 a.e./0,5 ml stungulyf, lausn Puregon 75 a.e./0,5 ml stungulyf, lausn Puregon 100 a.e./0,5 ml stungulyf, lausn Puregon 150 a.e./0,5 ml stungulyf, lausn Puregon 200 a.e./0,5 ml stungulyf, lausn Puregon 225 a.e./0,5 ml stungulyf, lausn
English: Puregon 150 IU/0.18 mL solution for injection Puregon 300 IU/0.36 mL solution for injection Puregon 600 IU/0.72 mL solution for injection Puregon 900 IU/1.08 mL solution for injection follitropin beta
Icelandic: Puregon 150 a.e./0,18 ml stungulyf, lausn Puregon 300 a.e./0,36 ml stungulyf, lausn Puregon 600 a.e./0,72 ml stungulyf, lausn Puregon 900 a.e./1,08 ml stungulyf, lausn follitrópín beta
English: Based on the results of comparative clinical studies, it is considered appropriate to give a lower total dosage of Puregon over a shorter treatment period than generally used for urinary FSH, not only in order to optimise follicular development but also to reduce the risk of unwanted ovarian hyperstimulation (see section 5.1).
Icelandic: Þetta á ekki aðeins við til að ná ákjósanlegasta þroska eggbús heldur einnig til að draga úr hættu á sjúklegri oförvun eggjastokka (sjá kafla 5.1).
English: Puregon 150 IU/0.18 mL solution for injection Puregon 300 IU/0.36 mL solution for injection Puregon 600 IU/0.72 mL solution for injection Puregon 900 IU/1.08 mL solution for injection
Icelandic: Puregon 150 a.e./0,18 ml stungulyf, lausn Puregon 300 a.e./0,36 ml stungulyf, lausn Puregon 600 a.e./0,72 ml stungulyf, lausn Puregon 900 a.e./1,08 ml stungulyf, lausn
English: VIAL TEXT Puregon 75 IU/0.5 mL
Icelandic: HETTUGLAS TEXTI Puregon 75 a.e./0,5 ml
English: Puregon 900 IU/1.08 mL injection follitropin beta
Icelandic: Puregon 900 a.e./1,08 ml stungulyf follitrópín beta
English: 1025 IU recombinant FSH activity/1.230 mL Net content 900 IU
Icelandic: FSH virkni/1,230 ml Heildarmagn 900 a.e.
English: Puregon 300 IU/0.36 mL solution for injection
Icelandic: Puregon 300 a.e./0,36 ml stungulyf, lausn
English: Do not mix Puregon with any other medicines.
Icelandic: Puregon við önnur lyf.
English: Ovarian torsion has been reported after treatment with gonadotropins, including Puregon.
Icelandic: Greint hefur verið frá snúningi eggjastokka (ovarian torsion) eftir meðferð með gónadótrópínum þ.m.t. Puregon.
English: 1 vial contains 0.5 mL follitropin beta corresponding to: 225 IU (450 IU/mL) recombinant follicle-stimulating hormone (FSH) activity.
Icelandic: 1 hettuglas inniheldur 0,5 ml af stungulyfi með follitrópín beta samsvarandi: 225 a.e. (450 a.e./ml) recombinant follicle-stimulating hormone (FSH) virkni.
English: Intramuscular (IM) and subcutaneous (SC) use.
Icelandic: Til notkunar í vöðva (i.m.) og undir húð (s.c.)
English: After intramuscular or subcutaneous administration of Puregon, maximum concentrations of FSH are reached within about 12 hours.
Icelandic: Eftir að Puregon hefur verið gefið í vöðva eða undir húð, næst hámarksþéttni FSH innan u.þ.b. 12 klst.
English: Puregon solution for injection comes in a glass vial.
Icelandic: Puregon stungulyf, lausn er í glerhettuglösum.
English: Medical conditions that contraindicate pregnancy should also be evaluated before starting treatment with Puregon.
Icelandic: Áður en meðferð með Puregon hefst á einnig að athuga aðra sjúkdóma sem mæla gegn þungun.
English: Puregon 300 IU/0.36 mL solution for injection EU/1/96/008/038
Icelandic: Puregon 300 a.e./0,36 ml stungulyf, lausn EU/1/96/008/038
English: CARTRIDGE TEXT Puregon 150 IU/0.18 mL
Icelandic: RÖRLYKJA TEXTI Puregon 150 a.e./0,18 ml
English: Puregon 600 IU/0.72 mL solution for injection EU/1/96/008/039
Icelandic: Puregon 600 a.e./0,72 ml stungulyf, lausn EU/1/96/008/039
English: Puregon 600 IU/0.72 mL injection follitropin beta
Icelandic: Puregon 600 a.e./0,72 ml stungulyf follitrópín beta s.c.
English: Puregon 300 IU/0.36 mL injection follitropin beta
Icelandic: Puregon 300 a.e./0,36 ml stungulyf follitrópín beta s.c.
English: Puregon 225 IU/0.5 mL solution for injection EU/1/96/008/032
Icelandic: Puregon 225 a.e./0,5 ml stungulyf, lausn EU/1/96/008/032
English: VIAL TEXT Puregon 50 IU/0.5 mL
Icelandic: HETTUGLAS TEXTI Puregon 50 a.e./0,5 ml
English: VIAL TEXT Puregon 200 IU/0.5 mL
Icelandic: HETTUGLAS TEXTI Puregon 200 a.e./0,5 ml
English: Date of first authorisation: 03 May 1996 Date of latest renewal: 29 May 2006
Icelandic: 29. maí 2006
English: OUTER CARTON TEXT Puregon 900 IU/1.08 mL 1 cartridge
Icelandic: YTRI UMBÚÐIR TEXTI 1 rörlykja með Puregon 900 a.e./1,08 ml
English: Ovarian torsion has occurred after treatment with gonadotropins including Puregon.
Icelandic: Snúningur eggjastokka hefur komið fyrir eftir meðferð með gónadótrópínum þ.m.t. Puregon.
English: Thromboembolic events, both in association with and separate from OHSS, have been reported following treatment with gonadotropins, including Puregon.
Icelandic: Greint hefur verið frá segareki með og án tengsla við oförvunarheilkenni eggjastokka eftir meðferð með gónadótrópínum þ.m.t. Puregon.
English: Puregon 150 IU/0.18 mL solution for injection EU/1/96/008/040
Icelandic: Puregon 150 a.e./0,18 ml stungulyf, lausn EU/1/96/008/040
English: One vial contains 225 IU recombinant follicle-stimulating hormone (FSH) in 0.5 mL aqueous solution.
Icelandic: Eitt hettuglas inniheldur 225 a.e. raðbrigða FSH (recombinant follicle-stimulating hormone) í 0,5 ml vatnslausn.
English: Puregon 900 IU/1.08 mL solution for injection EU/1/96/008/041
Icelandic: Puregon 900 a.e./1,08 ml stungulyf, lausn EU/1/96/008/041
English: Puregon 600 IU/0.72 mL solution for injection
Icelandic: Puregon 600 a.e./0,72 ml stungulyf, lausn
English: Puregon 900 IU/1.08 mL solution for injection
Icelandic: Puregon 900 a.e./1,08 ml stungulyf, lausn
English: There are great inter- and intra-individual variations in the response of the ovaries to exogenous gonadotrophins.
Icelandic: Skammtar handa konum Mikill munur er á svörun eggjastokka við utanaðkomandi gónadótrópínum milli einstaklinga og hjá hverjum einstaklingi.
English: One vial contains 22.5 microgram of protein (specific in vivo bioactivity equal to approximately 10,000 IU FSH / mg protein).
Icelandic: Hvert hettuglas inniheldur 22,5 míkróg af próteini (sértæk líffræðileg verkun in vivo sem jafngildir u.þ.b. 10.000 a.e. FSH / mg prótein).
English: Puregon 150 IU/0.18 mL injection follitropin beta
Icelandic: Puregon 150 a.e./0,18 ml stungulyf follitrópín beta s.c.
English: Puregon 225 IU/0.5 mL injection follitropin beta
Icelandic: Puregon 225 a.e./0,5 ml stungulyf, lausn follitrópín beta
English: For males and females
Icelandic: Karlar og konur
English: VIAL TEXT Puregon 100 IU/0.5 mL
Icelandic: HETTUGLAS TEXTI Puregon 100 a.e./0,5 ml
English: Breast complaints Metrorrhagia Ovarian cyst Ovarian enlargement Ovarian torsion Uterine enlargement Vaginal haemorrhage
Icelandic: Millitíðablæðingar Blöðrur á eggjastokkum Stækkun eggjastokka Snúningur á eggjastokkum
English: Puregon 75 IU/0.5 mL solution for injection EU/1/96/008/020
Icelandic: Puregon 75 a.e./0,5 ml stungulyf, lausn EU/1/96/008/020
English: Puregon 100 IU/0.5 mL solution for injection EU/1/96/008/023
Icelandic: Puregon 100 a.e./0,5 ml stungulyf, lausn EU/1/96/008/023
English: Puregon 150 IU/0.5 mL solution for injection EU/1/96/008/026
Icelandic: Puregon 150 a.e./0,5 ml stungulyf, lausn EU/1/96/008/026
English: Puregon 225 IU/0.5 mL solution for injection
Icelandic: Puregon 225 a.e./0,5 ml stungulyf, lausn
English: Puregon 150 IU/0.18 mL solution for injection
Icelandic: Puregon 150 a.e./0,18 ml stungulyf, lausn
English: For controlled ovarian stimulation, Puregon resulted in a higher number of oocytes retrieved at a lower total dose and with a shorter treatment period, when compared to urinary FSH.
Icelandic: Við stýrða örvun eggjastokka náðust fleiri eggfrumur við minni heildarskammt og styttri meðferðartíma ef Puregon var notað borið saman við FSH sem unnið er úr þvagi.
English: For ovulation induction, Puregon resulted in a lower median total dose and shorter median duration of treatment when compared to urinary FSH.
Icelandic: Við örvun eggloss þurfti minni heildarskammt og styttri meðferðartíma með Puregon borið saman við FSH sem unnið er úr þvagi.
English: OUTER CARTON TEXT Puregon 75 IU/0.5 mL 1, 5 or 10 vials
Icelandic: YTRI UMBÚÐIR TEXTI 1, 5 eða 10 hettuglös með Puregon 75 a.e./0,5 ml
English: Puregon 50 IU/0.5 mL solution for injection EU/1/96/008/017
Icelandic: Puregon 50 a.e./0,5 ml stungulyf, lausn EU/1/96/008/017
English: OUTER CARTON TEXT Puregon 225 IU/0.5 mL 1, 5 or 10 vials
Icelandic: YTRI UMBÚÐIR TEXTI 1, 5 eða 10 hettuglös með Puregon 225 a.e./0,5 ml
English: One vial contains 7.5 microgram of protein (specific in vivo bioactivity equal to approximately 10,000 IU FSH / mg protein).
Icelandic: Hvert hettuglas inniheldur 7,5 míkróg af próteini (sértæk líffræðileg verkun in vivo sem jafngildir u.þ.b. 10.000 a.e. FSH / mg prótein).
English: Puregon 75 IU/0.5 mL injection follitropin beta
Icelandic: Puregon 75 a.e./0,5 ml stungulyf, lausn follitrópín beta
English: Puregon 200 IU/0.5 mL solution for injection EU/1/96/008/029
Icelandic: Puregon 200 a.e./0,5 ml stungulyf, lausn EU/1/96/008/029
English: Puregon 200 IU/0.5 mL injection follitropin beta
Icelandic: Puregon 200 a.e./0,5 ml stungulyf, lausn follitrópín beta
English: The contents of the vial should be used immediately after piercing of the rubber stopper.
Icelandic: Lausnina skal nota strax eftir að stungið hefur verið á gúmmítappa hettuglassins.
English: OUTER CARTON TEXT Puregon 150 IU/0.5 mL 1, 5 or 10 vials
Icelandic: YTRI UMBÚÐIR TEXTI 1, 5 eða 10 hettuglös með Puregon 150 a.e./0,5 ml
English: Puregon 300 IU/0.36 mL solution for injection follitropin beta
Icelandic: Puregon 300 a.e./0,36 ml stungulyf, lausn follitrópín beta
English: Paediatric population There is no relevant use of Puregon in the paediatric population for the approved indication.
Icelandic: Börn Notkun Puregon á ekki við hjá börnum við samþykktu ábendingunni.
English: Puregon 150 IU/0.5 mL solution for injection
Icelandic: Puregon 150 a.e./0,5 ml stungulyf, lausn
English: Puregon 50 IU/0.5 mL injection follitropin beta
Icelandic: Puregon 50 a.e./0,5 ml stungulyf, lausn follitrópín beta
English: The concurrent determination of serum oestradiol levels may also be useful.The patients should be advised of the potential risks of multiple births before starting treatment.
Icelandic: Skýra skal sjúklingum frá hugsanlegri hættu á fjölburafæðingum áður en meðferð hefst.
English: OUTER CARTON TEXT Puregon 300 IU/0.36 mL 1 cartridge
Icelandic: YTRI UMBÚÐIR TEXTI 1 rörlykja með Puregon 300 a.e./0,36 ml
English: VIAL TEXT Puregon 150 IU/0.5 mL
Icelandic: HETTUGLAS TEXTI Puregon 150 a.e./0,5 ml
English: Puregon 75 IU/0.5 mL solution for injection
Icelandic: Puregon 75 a.e./0,5 ml stungulyf, lausn
English: Puregon 600 IU/0.72 mL solution for injection follitropin beta
Icelandic: Puregon 600 a.e./0,72 ml stungulyf, lausn follitrópín beta
English: Puregon 200 IU/0.5 mL solution for injection
Icelandic: Puregon 200 a.e./0,5 ml stungulyf, lausn
English: Puregon 100 IU/0.5 mL solution for injection
Icelandic: Puregon 100 a.e./0,5 ml stungulyf, lausn
English: Puregon 100 IU/0.5 mL injection follitropin beta
Icelandic: Puregon 100 a.e./0,5 ml stungulyf, lausn follitrópín beta
English: What Puregon contains
Icelandic: Puregon inniheldur
English: Puregon 150 IU/0.18 mL solution for injection follitropin beta
Icelandic: Puregon 150 a.e./0,18 ml stungulyf, lausn follitrópín beta
English: OUTER CARTON TEXT Puregon 600 IU/0.72 mL 1 cartridge
Icelandic: YTRI UMBÚÐIR TEXTI 1 rörlykja með Puregon 600 a.e./0,72 ml
English: Subcutaneous (SC) use.
Icelandic: Til notkunar undir húð (s.c.)
English: Puregon 900 IU/1.08 mL solution for injection follitropin beta
Icelandic: Puregon 900 a.e./1,08 ml stungulyf, lausn follitrópín beta
English: OUTER CARTON TEXT Puregon 150 IU/0.18 mL 1 cartridge
Icelandic: YTRI UMBÚÐIR TEXTI 1 rörlykja með Puregon 150 a.e./0,18 ml
English: You should use sterile disposable syringes and needles for the administration of Puregon.
Icelandic: Puregon átt þú að nota sæfða einnota sprautu og nálar.
English: OUTER CARTON TEXT Puregon 100 IU/0.5 mL 1, 5 or 10 vials
Icelandic: YTRI UMBÚÐIR TEXTI 1, 5 eða 10 hettuglös með Puregon 100 a.e./0,5 ml
English: There is a slightly increased risk of a pregnancy outside the uterus (an ectopic pregnancy).
Icelandic: Örlítið aukin hætta er á utanlegsfóstri.
English: Ovarian and Other Reproductive System Tumours There have been reports of ovarian and other reproductive system tumors in women who have had infertility treatment.
Icelandic: Greint hefur verið frá æxlum í eggjastokk eða öðrum æxlunarfærum hjá konum sem hafa gengist undir meðferð við ófrjósemi.
English: Puregon 50 IU/0.5 mL solution for injection
Icelandic: Puregon 50 a.e./0,5 ml stungulyf, lausn
English: OUTER CARTON TEXT Puregon 200 IU/0.5 mL 1, 5 or 10 vials
Icelandic: YTRI UMBÚÐIR TEXTI 1, 5 eða 10 hettuglös með Puregon 200 a.e./0,5 ml
English: Multiple gestation, especially high order, carries an increased risk of adverse maternal (pregnancy and delivery complications) and perinatal (low birth weight) outcomes.For anovulatory women undergoing ovulation induction, monitoring follicular development with transvaginal ultrasonography may aid in determining whether or not to continue the cycle in order to reduce the risk of multiple pregnancies.
Icelandic: Við örvun eggloss hjá konum sem hafa ekki egglos getur eftirlit með þroska eggbús með ómskoðun um leggöng hjálpað til við að ákveða hvort halda eigi meðferðarlotunni áfram eða hætta henni til þess að draga úr líkum á fjölburaþungun.
English: Puregon 150 IU/0.5 mL solution for injection follitropin beta
Icelandic: Puregon 150 a.e./0,5 ml stungulyf, lausn follitrópín beta
English: For use only with the Puregon Pen.
Icelandic: Til notkunar undir húð (s.c.) Aðeins til notkunar í Puregon Pen.
English: Merck Sharp & Dohme, Lda Tel: + 351 214 465700 clic@merck.com
Icelandic: + 351 214 465700 clic@merck.com
English: Puregon 150 IU/0.5 mL injection follitropin beta
Icelandic: Puregon 150 a.e./0,5 ml stungulyf follitrópín beta i.m./s.c.
English: Oral use blister (PVC/PVDCalu/PET/paper)
Icelandic: (PVC/PVDCál/PET/pappír)
English: Immediate Packaging Pack size
Icelandic: Til inntöku þynnupakkning
English: 200 mg Film-coated tablet
Icelandic: Filmuhúðuð tafla
English: Strength Pharmaceutical Form Route of Administration
Icelandic: ESB markaðsleyfisnúmer (Sér)heiti Styrkleiki Lyfjaform Íkomuleið Innri umbúðir
English: Do not repeat this before each daily injection, otherwise you will not have enough Movymia for 28 days.
Icelandic: Ekki endurtaka þetta fyrir hverja daglega inndælingu, annars verður ekki nóg Movymia fyrir 28 daga.
English: Movymia can be given with or without food.
Icelandic: Movymia má gefa með eða án matar.
English: Your doctor will advise you and decide how long you should be treated with Movymia.
Icelandic: Hann mun ráðleggja þér og ákveða hversu lengi þú átt að fá meðferð með Movymia.
English: Date of first authorisation: 11 January 2017
Icelandic: 11. janúar 2017
English: Distributor: XXXXXXXXXXX
Icelandic: Dreifingaraðili: XXXXXXXXXXX
English: 1103 Budapest Hungary
Icelandic: 1103 Budapest
English: Placebo (N = 544) (%)
Icelandic: Lyfleysa (N=544) (%)
English: The total duration of treatment with Movymia should not exceed 24 months.
Icelandic: Meðferðarlengd með Movymia ætti ekki að vera lengri en 24 mánuðir.
English: Laboratorio STADA, S.L.
Icelandic: Laboratorio STADA, S.L. Tel:
English: STADA Pharma Bulgaria EOOD Teл.
Icelandic: STADA Pharma Bulgaria EOOD
English: Manufacturer Gedeon Richter Plc.
Icelandic: Framleiðandi Gedeon Richter Plc.
English: Movymia must not be used with any other pen.
Icelandic: Movymia má ekki nota með neinum öðrum penna.
English: Teriparatide has no or negligible influence on the ability to drive and use machines.
Icelandic: Teriparatid hefur engin eða óveruleg áhrif á hæfni til aksturs eða notkunar véla.
English: The Movymia Pen has a service life of two years.
Icelandic: Movymia Pen endist til notkunar í tvö ár.
English: Inject Movymia each day for as long as your doctor prescribes it for you.
Icelandic: Notaðu Movymia daglega eins lengi og læknirinn hefur gefið fyrirmæli um.
English: If you are considering stopping Movymia treatment, please discuss this with your doctor.
Icelandic: Ef þú íhugar að hætta notkun Movymia skalt þú ræða það við lækninn.
English: Injecting Movymia - Before you inject Movymia, clean your skin where you intend to inject (thigh or abdomen) as instructed by your doctor.
Icelandic: Movymia - Áður en þú sprautar Movymia, skaltu hreinsa húðina þar sem þú ætlar að sprauta (læri eða kvið) samkvæmt leiðbeiningum læknisins.
English: Abbreviations: N = number of patients randomly assigned to each treatment group; CI = confidence interval.
Icelandic: N = fjöldi sjúklinga sem handahófskennt var raðað á annan hvorn meðferðararminn; CI = öryggisbil (confidence interval)
English: The amount of Movymia left in the cartridge is less than 80 microlitres.
Icelandic: Magn Movymia sem er eftir í rörlykjunni er minna en 80 míkrólítrar.
English: Follow the instructions given in the table if you have any questions regarding the use of Movymia Pen:
Icelandic: Fylgið leiðbeiningunum í töflunni ef fram koma spurningar um notkun Movymia Pen:
English: Movymia contains a clear and colourless solution.
Icelandic: Movymia inniheldur tæra og litlausa lausn.
English: What Movymia is and what it is used for What you need to know before you use Movymia How to use Movymia
Icelandic: Upplýsingar um Movymia og við hverju það er notað Áður en byrjað er að nota Movymia Hvernig nota á Movymia
English: • Ypsomed mylife Clickfine 29 to 31 gauge (diameter 0.25 - 0.33 mm) and 12, 10, 8 or 6 mm length
Icelandic: Ypsomed mylife Clickfine stærð 29 til 31 (þvermál 0,25 - 0,33 mm) og 12, 10, 8 eða 6 mm lengd
English: • A damp cloth is sufficient to clean the Movymia Pen.
Icelandic: Rakur klútur nægir til að hreinsa Movymia Pen.
English: Movymia may increase calcium in your blood or urine.
Icelandic: Movymia getur valdið aukningu á kalki í blóði eða þvagi.
English: • the pen being used with a medical device, accessories or consumables other than those recommended by XXXXXXXXXXX.
Icelandic: • notkunar pennans með öðrum lækningabúnaði, fylgihlutum eða neysluvörum en þeim sem XXXXXXXXXXX.
English: Do not use your Movymia Pen to inject any other medicine (e.g. insulin).
Icelandic: Ekki má nota Movymia Pen til að sprauta öðrum lyfjum (til dæmis insúlíni).
English: Children and adolescents Movymia should not be used in children and adolescents (aged less than 18 years).
Icelandic: Movymia má ekki gefa börnum eða unglingum (undir 18 ára aldri).
English: You can use Movymia for up to 28 days after the first injection, as long as the cartridge/pen with the cartridge inserted is stored in a refrigerator (2 °C to 8 °C).
Icelandic: Þú getur notað Movymia í allt að 28 daga eftir fyrstu sprautun, svo fremi sem rörlykjan/penninn með rörlykjunni er geymdur í kæli (2°C til 8°C).
English: Use your Movymia Pen only as prescribed by your doctor, in this instructions for use and the Movymia package leaflet.
Icelandic: Notið Movymia Pen aðeins eins og læknirinn hefur mælt fyrir um, eins og fram kemur í þessum notkunarleiðbeiningum og í Movymia fylgiseðlinum.
English: Marketing Authorisation Holder STADA Arzneimittel AG Stadastrasse 2-18
Icelandic: Markaðsleyfishafi STADA Arzneimittel AG Stadastrasse 2-18
English: Some patients get dizzy or get a fast heartbeat after the first few doses of Movymia.
Icelandic: Sumir sjúklingar geta fundið fyrir svima eða hraðari hjartslætti við notkun fyrstu skammtana af Movymia.
English: What Movymia is and what it is used for
Icelandic: Upplýsingar um Movymia og við hverju það er notað
English: The warranty covers manufacturing and material defects of your Movymia Pen for two years of use, from purchase.
Icelandic: Ábyrgðin nær til framleiðslu og efnislegra galla í Movymia Pen á tveggja ára notkunartíma, frá kaupum.
English: • BD Micro-Fine Ultra needles 29 to 31 gauge (diameter 0.25 - 0.33 mm) and 12.7, 8 or 5 mm length Pen needles from other manufacturers can be used according to their stated compatibility details.
Icelandic: BD Micro-Fine Ultra nálar í stærð 29 til 31 (þvermál 0,25 - 0,33 mm) og 12,7 eða 8 eða 5 mm lengd Nota má pennanálar frá öðrum framleiðendum í samræmi við yfirlýsingar þeirra um samhæfi.